Health Blueprint

Back to Longevity News

News summary

Traded: Venture Capital 🦄 on Instagram: "Basecamp Research, a London-based AI biotech led by CEO Glen Gowers, raised $140 million in Series C funding led by S32, with participation from Anthropic’s Anthology Fund, Catalio Capital Management, European Tech Collective, Firebrand River Capital, Inception Fund, King Philanthropies, NATO Innovation Fund, NVIDIA, PostScriptum, Redalpine, The Rockefeller Foundation, Singular, Sovereign AI, and True Ventures. The company will use the funding to expand operations and development of its therapeutic-design platform, which combines biological foundation models with DNA-writing technology for cell therapies, gene therapies, enzyme design, and target discovery. FOUNDERS: Glen Gowers & Oliver Vince INVESTORS: S32, Anthropic’s Anthology Fund, Catalio Capital Management, European Tech Collective, Firebrand River Capital, Inception Fund, King Philanthropies, NATO Innovation Fund, NVIDIA, PostScriptum, Redalpine, The Rockefeller Foundation, Singular, Sovereign AI & True Ventures ROUND: Series C AMOUNT: $140,000,000 HQ: London, United Kingdom #VentureCapital #BasecampResearch #GlenGowers #OliverVince #TradedVC"

Source: traderVC • Published: 23 Sept 2026, 17:30

Summarized by Masters of Longevity from traderVC.

Basecamp Research: a news item about an AI biotech funding round and what readers can expect about its growth and platform ambitions.

Traded: Venture Capital 🦄 on Instagram: "Basecamp Research, a London-based AI biotech led by CEO Glen Gowers, raised $140 million in Series C funding led by S32, with participation from Anthropic’s Anthology Fund, Catalio Capital Management, European Tech Collective, Firebrand River Capital, Inception Fund, King Philanthropies, NATO Innovation Fund, NVIDIA, PostScriptum, Redalpine, The Rockefeller Foundation, Singular, Sovereign AI, and True Ventures. The company will use the funding to expand operations and development of its therapeutic-design platform, which combines biological foundation models with DNA-writing technology for cell therapies, gene therapies, enzyme design, and target discovery. FOUNDERS: Glen Gowers & Oliver Vince INVESTORS: S32, Anthropic’s Anthology Fund, Catalio Capital Management, European Tech Collective, Firebrand River Capital, Inception Fund, King Philanthropies, NATO Innovation Fund, NVIDIA, PostScriptum, Redalpine, The Rockefeller Foundation, Singular, Sovereign AI & True Ventures ROUND: Series C AMOUNT: $140,000,000 HQ: London, United Kingdom #VentureCapital #BasecampResearch #GlenGowers #OliverVince #TradedVC"
Key Takeaways
  • The company raised $140 million in a Series C financing round led by S32.
  • Investors included Anthropic’s Anthology Fund, NVIDIA, The Rockefeller Foundation, and NATO Innovation Fund.
  • Funding will expand operations and develop a platform using biological foundation models plus DNA-writing for therapies.
Read the full article at traderVC ↗

Continue exploring

Recommended MoL Picks

MoL PickCan You Really Measure Whether You’re Aging More Slowly?A younger epigenetic-age score can look like proof that an intervention is working. A major new analysis shows which clocks detect change—and why movement is not yet the same as longer healthspan.MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.MoL PickPlan Your Health Tests in Three MinutesThe free Personal Health Diagnostics Planner turns a short questionnaire into a ranked, personalised PDF: a clearer starting point for deciding which health checks deserve attention now.